PFT with Reversibility at Dr. Essa Lab

PFT with Reversibility at Dr. Essa Lab

Pulmonary Function Testing (PFT) with Reversibility is a highly specialized, non-invasive diagnostic procedure utilized to evaluate the physiological performance of the respiratory system. At Dr. Essa Lab, we conduct this essential test using state-of-the-art spirometry equipment to measure lung volumes, capacities, and airflow dynamics. The primary clinical objective of a PFT with Reversibility is to determine whether airway obstruction is present and, crucially, whether this obstruction can be reversed through the administration of a bronchodilator medication. This diagnostic distinction is fundamental in differentiating between chronic respiratory conditions such as bronchial asthma, which typically demonstrates significant reversibility, and chronic obstructive pulmonary disease (COPD), which generally exhibits fixed or only partially reversible airflow limitation.

By measuring the volume of air an individual can inhale and exhale, as well as the speed at which they can move air out of their lungs, this test provides invaluable objective data. It serves as a cornerstone for pulmonologists, allergists, and internal medicine specialists in establishing accurate diagnoses, grading disease severity, and tailoring personalized therapeutic regimens. At Dr. Essa Lab, our commitment to diagnostic excellence ensures that each PFT with Reversibility is performed under strict quality control standards, utilizing advanced computerized spirometers that conform to the joint guidelines of the American Thoracic Society (ATS) and the European Respiratory Society (ERS). Whether you are experiencing chronic respiratory symptoms or requiring pre-operative pulmonary clearance, our experienced clinical team is dedicated to delivering precise, reliable, and timely results to guide your healthcare journey.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the clinical accuracy and reproducibility of your PFT with Reversibility at Dr. Essa Lab, strict adherence to patient preparation guidelines is essential. Because the test measures the immediate physiological response of your airways to a bronchodilator, any pre-existing medications or lifestyle factors that alter airway caliber must be managed prior to the test. Please observe the following preparation instructions:

• Avoid using short-acting bronchodilators (such as Salbutamol, Albuterol, or Ipratropium inhalers) for at least 4 to 6 hours before the test.
• Discontinue long-acting beta-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) for 12 to 24 hours prior to your scheduled appointment, as advised by your referring physician.
• Refrain from smoking cigarettes, using e-cigarettes, or consuming any form of nicotine for at least 8 hours before the test, as nicotine causes acute bronchoconstriction.
• Avoid consuming caffeine-containing beverages, including coffee, tea, energy drinks, and colas, for at least 4 hours prior to the test, as caffeine has mild bronchodilatory properties.
• Do not eat a heavy meal for at least 2 hours before the procedure; a full stomach can restrict the descent of the diaphragm and artificially limit lung expansion.
• Wear loose-fitting, comfortable clothing that does not restrict your chest or abdominal expansion during deep breathing maneuvers.
• Avoid vigorous physical exercise or strenuous activity for at least 2 hours before your test.
• If you have recently had a respiratory infection, chest pain, a recent heart attack, or eye, thoracic, or abdominal surgery, please inform our clinical staff beforehand, as these may be temporary contraindications.

During the Procedure

The PFT with Reversibility is a safe, structured, and interactive procedure performed by a trained respiratory technician at Dr. Essa Lab. The entire process takes approximately 30 to 45 minutes and is divided into three distinct phases. First, baseline spirometry is performed. You will sit comfortably in an upright position. A soft, comfortable clip will be placed on your nose to prevent nasal airflow, ensuring all breathing occurs through your mouth. You will be instructed to seal your lips tightly around a sterile, single-use disposable mouthpiece connected to the spirometer. Under the precise guidance of our technician, you will take a deep breath in until your lungs are completely full, and then immediately blast the air out as hard, fast, and long as possible into the mouthpiece, continuing to blow until your lungs are completely empty (typically for at least 6 seconds). This maneuver is repeated at least three times to ensure consistency and reproducibility.

Second, the bronchodilator phase begins. Once stable baseline measurements are recorded, you will be administered a standard dose of a fast-acting bronchodilator (typically 4 separate puffs of Salbutamol/Albuterol) via a spacer device. You will then rest quietly in our waiting area for 10 to 15 minutes, allowing the medication to act on your bronchial smooth muscles. Third, the post-bronchodilator spirometry is performed. You will return to the testing station and repeat the deep inhalation and forceful exhalation maneuvers. The spirometer’s advanced software will automatically compare your baseline and post-bronchodilator measurements, calculating the percentage and absolute volume change in your lung function. Throughout the procedure, our technician will monitor you closely to ensure your safety and comfort.

When is a PFT with Reversibility Performed?

Diagnosing Bronchial Asthma

Bronchial asthma is a chronic inflammatory disorder of the airways characterized by bronchial hyperresponsiveness and variable airflow obstruction. Physicians frequently request a PFT with Reversibility at Dr. Essa Lab when a patient presents with classic asthma symptoms such as episodic wheezing, chest tightness, and shortness of breath. The test is crucial because it objectively demonstrates the hallmark of asthma: airway reversibility. A significant improvement in lung function parameters after the inhalation of a bronchodilator confirms that the airway narrowing is temporary and responsive to treatment, establishing a definitive diagnosis of asthma and ruling out fixed airway diseases.

Evaluating Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD), which includes chronic bronchitis and emphysema, is a progressive lung condition primarily caused by long-term exposure to irritating gases or particulate matter, most commonly cigarette smoke. When patients present with chronic dyspnea, productive cough, and a history of smoking, a PFT with Reversibility is performed to assess the degree of fixed airflow limitation. Unlike asthma, COPD typically shows incomplete or absent reversibility. Identifying this fixed obstruction helps clinicians confirm a diagnosis of COPD, grade its severity according to global initiatives, and formulate long-term management strategies.

Investigating Unexplained Chronic Cough

A chronic cough, defined as a cough lasting eight weeks or longer, is a common clinical challenge with numerous potential etiologies. When initial examinations and chest X-rays fail to reveal a cause, a PFT with Reversibility is indicated. Cough-variant asthma is a specific phenotype where cough is the primary or sole symptom, without obvious wheezing. By performing this test, clinicians can detect subtle airway hyperresponsiveness and reversibility, allowing for the targeted initiation of inhaled corticosteroid therapy, which often resolves the chronic cough when other treatments have failed.

Assessing Unexplained Shortness of Breath (Dyspnea)

Shortness of breath, or dyspnea, is a subjective symptom that can stem from cardiac, pulmonary, neuromuscular, or systemic origins. A PFT with Reversibility at Dr. Essa Lab serves as an essential first-line diagnostic tool to evaluate the pulmonary contribution to dyspnea. By measuring the volume and flow of air, the test helps differentiate between obstructive airway diseases (like asthma and COPD) and restrictive lung patterns (suggestive of interstitial lung disease or chest wall abnormalities). The reversibility component further refines this differentiation, guiding clinicians toward appropriate specialized investigations.

Monitoring Therapeutic Response to Respiratory Medications

For patients with established chronic respiratory diseases, a PFT with Reversibility is not merely a diagnostic tool but a vital monitoring instrument. Physicians regularly order this test to objectively evaluate the efficacy of prescribed pharmacological interventions, such as inhaled corticosteroids, long-acting bronchodilators, or biologic therapies. By comparing current test results with baseline measurements, clinicians can determine if the patient’s lung function has stabilized, improved, or deteriorated, allowing for precise adjustments to medication dosages and overall management plans.

What Does a PFT with Reversibility Detect?

A PFT with Reversibility is highly sensitive and capable of detecting a wide spectrum of physiological abnormalities and clinical parameters. Specifically, the test detects and evaluates:

• Baseline Forced Vital Capacity (FVC), measuring the total volume of air exhaled forcefully.
• Baseline Forced Expiratory Volume in 1 second (FEV1), indicating airway caliber and flow.
• The baseline FEV1/FVC ratio, the primary index used to identify obstructive lung patterns.
• Significant bronchodilator reversibility, defined as an increase in FEV1 or FVC of 12% or more and an absolute increase of 200 mL or more.
• Fixed airway obstruction, characterized by a persistently low FEV1/FVC ratio post-bronchodilator.
• Restrictive ventilatory patterns, suggested by a proportional reduction in both FVC and FEV1 with a normal or elevated ratio.
• Mixed ventilatory defects, combining features of both obstruction and restriction.
• Early small airway disease, indicated by reductions in Forced Expiratory Flow between 25% and 75% of vital capacity (FEF25-75).
• Peak Expiratory Flow (PEF) rates, reflecting the maximum speed of expiration.
• The severity of obstructive lung disease, graded from mild to very severe based on post-bronchodilator FEV1 percentages.
• Airway hyperreactivity and smooth muscle responsiveness.
• Suboptimal patient effort or poor technique, identified through quality control flow-volume loops.
• Extrathoracic airway obstructions, visible as flattening of the inspiratory or expiratory loops.
• Intrathoracic airway obstructions, affecting the shape of the expiratory curve.
• Physiological improvements following therapeutic trials of bronchodilators.
• Respiratory muscle weakness, suggested by low lung volumes in the absence of intrinsic lung disease.
• Occupational lung disease patterns resulting from dust, chemical, or fume exposure.
• Pre-operative pulmonary risk, assessing a patient’s capacity to tolerate general anesthesia and major thoracic or abdominal surgery.
• Progression of chronic respiratory conditions over time.
• The presence of Asthma-COPD Overlap Syndrome (ACOS), characterized by features of both conditions.
• The impact of environmental allergens on respiratory function.
• The physiological efficacy of pulmonary rehabilitation programs.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that timely diagnostic results are critical for patient peace of mind and prompt clinical decision-making. The raw data from your PFT with Reversibility is generated immediately upon completion of the test. This data is then meticulously reviewed, interpreted, and signed off by our consultant pulmonologists or qualified clinical pathologists to ensure absolute accuracy. Typically, the finalized, comprehensive diagnostic report is available within 24 hours of your test.

Dr. Essa Lab provides multiple convenient ways to access your reports. Patients can collect physical copies of their reports from any of our conveniently located diagnostic centers across Karachi and other major cities. Additionally, we offer secure online report access through our official website and mobile application. By entering your patient credentials, you can easily view, download, and share your high-resolution digital reports with your referring physician from the comfort of your home, ensuring seamless continuity of care.

PFT with Reversibility Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Forced Expiratory Volume in 1 second (FEV1)	>= 80% of predicted value	< 80% of predicted value (indicates airway obstruction or restriction)
Forced Vital Capacity (FVC)	>= 80% of predicted value	< 80% of predicted value (suggests restriction or severe air trapping)
FEV1/FVC Ratio	>= 70% (or above the lower limit of normal)	< 70% (diagnostic of obstructive airway disease)
Post-Bronchodilator FEV1 Change	< 12% and/or < 200 mL increase from baseline	>= 12% and >= 200 mL increase (positive reversibility, highly suggestive of asthma)
Post-Bronchodilator FVC Change	< 12% and/or < 200 mL increase from baseline	>= 12% and >= 200 mL increase (indicates reversible air trapping)
Forced Expiratory Flow 25-75% (FEF25-75)	60% to 120% of predicted value	< 60% of predicted value (indicates early or small airway disease)
Peak Expiratory Flow (PEF)	>= 80% of predicted value	< 80% of predicted value (indicates large airway narrowing or poor patient effort)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for PFT with Reversibility?

• Experienced Healthcare Professionals: Our tests are conducted by highly trained respiratory technicians and interpreted by expert consultant pulmonologists.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the testing process.
• Quality Diagnostic Services: Dr. Essa Lab is committed to maintaining the highest standards of diagnostic accuracy and clinical excellence.
• Professional Reporting: We provide detailed, comprehensive, and easy-to-understand reports with precise physiological interpretations.
• Modern Diagnostic Approach: We utilize state-of-the-art, computerized spirometry systems that adhere to international ATS/ERS standards.
• Comfortable Environment: Our diagnostic centers are designed to provide a welcoming, hygienic, and stress-free experience for all patients.
• Convenient Locations: With an extensive network of branches across Karachi and beyond, accessing our diagnostic services is highly convenient.
• Commitment to Accurate Diagnosis: Established in 1987, Dr. Essa Lab has built decades of trust through reliable, evidence-based diagnostic reporting.